Question 1

MRK vs PACB: which stock scores better overall?

Accepted Answer

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.7/10 versus Pacific Biosciences of Californ (PACB) at 5.5/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: MRK or PACB?

Accepted Answer

Pacific Biosciences of Californ (PACB) scores higher on Growth (7.3/10 vs 6.2/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Pacific Biosciences of Californ reports (13.8% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is MRK or PACB more attractively valued?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Value (7.2/10 vs 6.4/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about MRK vs PACB?

Accepted Answer

There are 27 analysts covering MRK with a consensus price target of $129.74, and 6 analysts covering PACB with a consensus target of $2.38. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: MRK or PACB?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 3.4/10). Net profit margin: MRK at 13.6%, PACB at 0.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: MRK or PACB?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 5.7/10). Market beta: MRK at 0.28, PACB at 2.33. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of MRK and PACB?

Accepted Answer

Merck & Company, Inc. (MRK) has a market capitalisation of $277.0B, while Pacific Biosciences of Californ (PACB) has a market cap of $497M. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do MRK or PACB pay dividends?

Accepted Answer

MRK pays a dividend yield of 3.03%, while PACB does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.

Merck & Company, Inc. vs Pacific Biosciences of Californ — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals